Literature DB >> 15013432

NF-kappaB-dependent induction of osteoprotegerin by Porphyromonas gingivalis in endothelial cells.

Michiyo Kobayashi-Sakamoto1, Kimiharu Hirose, Emiko Isogai, Itsuo Chiba.   

Abstract

Porphyromonas gingivalis is a major etiological pathogen of adult periodontitis characterized by alveolar bone resorption. Vascular endothelial cells supply many inflammatory cytokines into periodontal tissue. However, whether the cells contribute to bone metabolism in periodontitis remains unknown. In this study, we investigated the effect of P. gingivalis on osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) production, both of which are key regulators of bone metabolism, in human microvascular endothelial cells (HMVECs). We showed that P. gingivalis upregulated expression of OPG but not RANKL mRNA in HMVEC. P. gingivalis induced NF-kappaB activation, and the induction of OPG in HMVEC by the pathogen was blocked by the inhibitors of NF-kappaB. In addition, incubation of OPG with P. gingivalis supernatant resulted in loss of the protein. These results indicate that P. gingivalis-stimulated HMVEC secrete OPG via a NF-kappaB-dependent pathway, while the OPG is partly degraded by the bacteria. Thus, microvascular endothelial cells can act as a source of OPG and thereby may play an important role in regulating bone metabolism in periodontitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013432     DOI: 10.1016/j.bbrc.2004.01.024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  MicroRNA-181b regulates NF-κB-mediated vascular inflammation.

Authors:  Xinghui Sun; Basak Icli; Akm Khyrul Wara; Nathan Belkin; Shaolin He; Lester Kobzik; Gary M Hunninghake; Miguel Pinilla Vera; Timothy S Blackwell; Rebecca M Baron; Mark W Feinberg
Journal:  J Clin Invest       Date:  2012-05-24       Impact factor: 14.808

2.  Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin.

Authors:  Emma Board-Davies; Rachael Moses; Alastair Sloan; Phil Stephens; Lindsay C Davies
Journal:  Stem Cells Transl Med       Date:  2015-09-16       Impact factor: 6.940

3.  Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.

Authors:  J-J Body; P Bergmann; S Boonen; J-P Devogelaer; E Gielen; S Goemaere; J-M Kaufman; S Rozenberg; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-02-04       Impact factor: 4.507

4.  Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients.

Authors:  Sandy H S Hassan; Mahmoud I El-Refai; Noha A Ghallab; Rehab Fawzy Kasem; Olfat G Shaker
Journal:  Dis Markers       Date:  2015-02-28       Impact factor: 3.434

Review 5.  The Role of Osteoprotegerin and Its Ligands in Vascular Function.

Authors:  Luc Rochette; Alexandre Meloux; Eve Rigal; Marianne Zeller; Yves Cottin; Catherine Vergely
Journal:  Int J Mol Sci       Date:  2019-02-06       Impact factor: 5.923

6.  Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact.

Authors:  Penny E Reid; Nicola J Brown; Ingunn Holen
Journal:  Mol Cancer       Date:  2009-07-15       Impact factor: 27.401

7.  Transglutaminase-2 Is Involved in Expression of Osteoprotegerin in MG-63 Osteosarcoma Cells.

Authors:  Hye Ja Lee; Chang Hoon Lee
Journal:  Biomol Ther (Seoul)       Date:  2013-05-30       Impact factor: 4.634

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.